Status:
COMPLETED
Hyoscine Butyl-bromide Versus Ondansetron for Nausea and Vomiting During Cesarean Section Under Spinal Anesthesia
Lead Sponsor:
Assiut University
Conditions:
Vomiting
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
overall incidence of intraoperative nausea and vomiting(IONV) during regional anesthesia for cesarean section is extremely variable, up to 80 percent , depending on the anesthetic technique used (spin...
Eligibility Criteria
Inclusion
- All patients 18-40 years of age,
- American Society of Anaesthesiologists (ASA) classification class I and II
- patients scheduled for elective or semi-elective surgery (category 3 and 4 Caesarean section) under spinal anaesthesia
- Single baby pregnancy of more than 32 weeks
Exclusion
- height \< 150 or \> 180 cm,
- Body mass index (BMI) \>35 kg m-2,
- Contraindication or refusal to undergo regional anaesthesia,
- any cardiovascular disease including arrhythmias, Patients on β-adrenergic blockers or any drugs that may alter the normal response to the study drug,
- history of PONV or motion sickness,
- had taken antiemetic medication in the previous week,
- had a history of hyperemesis gravidarum
Key Trial Info
Start Date :
October 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 12 2022
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT04785118
Start Date
October 1 2021
End Date
December 12 2022
Last Update
March 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University hospital
Asyut, Egypt, 11111